After Alfasigma licensing deal, Lynavoy picks up FDA nod
19 Mar 2026 //
FIERCE PHARMA
Glaxosmithkline’s Lynavoy Receives Approval in US
17 Mar 2026 //
FDA
Alfasigma`s $690M Deal For GSK Itch Drug Awaiting FDA Decision
09 Mar 2026 //
FIERCE BIOTECH
FDA Accepts NDA for Linerixibat in PBC-Related Itch
07 Jun 2025 //
PRESS RELEASE
GSK posts phase 3 itch data as it closes in on FDA approval
09 May 2025 //
PRESS RELEASE
GSK’s itch prospect hits mark in phase 3 liver disease trial
20 Nov 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support